Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
15.69
+0.06 (0.38%)
Apr 30, 2025, 3:04 PM CST
SHE:002737 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 293.97 | 492.05 | 1,119 | 867.22 | 704.74 | 584.45 | Upgrade
|
Depreciation & Amortization | 178.98 | 178.98 | 181.2 | 268.81 | 167.77 | 149.15 | Upgrade
|
Other Amortization | 5.67 | 5.67 | 2.05 | 1.77 | 2.17 | 1.64 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.24 | 0.24 | -3.23 | -7.43 | -47.77 | 5.41 | Upgrade
|
Asset Writedown & Restructuring Costs | 25.79 | 25.79 | 0.48 | 26.43 | 29.68 | 38.34 | Upgrade
|
Loss (Gain) From Sale of Investments | -11.95 | -11.95 | -30.58 | 9.92 | -26.36 | -14.23 | Upgrade
|
Provision & Write-off of Bad Debts | 7.63 | 7.63 | -4.6 | 1.06 | 27.05 | -6.56 | Upgrade
|
Other Operating Activities | 143.09 | 47.6 | 54.88 | 39.18 | 52.53 | 44.18 | Upgrade
|
Change in Accounts Receivable | -415.02 | -415.02 | 77.04 | 26.33 | 38.45 | 332.38 | Upgrade
|
Change in Inventory | -25.49 | -25.49 | -241.47 | 73.5 | -152.67 | 101.66 | Upgrade
|
Change in Accounts Payable | -634.38 | -634.38 | -286.2 | 662.12 | 57.9 | -82.14 | Upgrade
|
Change in Other Net Operating Assets | 2.77 | 2.77 | 25.66 | 15.16 | 10.43 | - | Upgrade
|
Operating Cash Flow | -410.06 | -307.48 | 889.69 | 1,975 | 865.23 | 1,170 | Upgrade
|
Operating Cash Flow Growth | - | - | -54.96% | 128.30% | -26.04% | 19.21% | Upgrade
|
Capital Expenditures | -85.9 | -92.79 | -149.16 | -152.9 | -118.31 | -212.73 | Upgrade
|
Sale of Property, Plant & Equipment | 0.33 | 0.33 | 4.05 | 3.98 | 0.69 | 97.06 | Upgrade
|
Cash Acquisitions | - | - | - | - | -1.1 | - | Upgrade
|
Investment in Securities | -1,144 | 60.53 | 147.7 | -517.45 | -790.76 | -98.39 | Upgrade
|
Other Investing Activities | 25.48 | 34.47 | 33.61 | 21.94 | 19.76 | 10.21 | Upgrade
|
Investing Cash Flow | -1,205 | 2.54 | 36.2 | -644.43 | -889.72 | -203.85 | Upgrade
|
Short-Term Debt Issued | - | 0.02 | 4.43 | - | - | - | Upgrade
|
Long-Term Debt Issued | - | - | 10 | 420 | 306.58 | 350.52 | Upgrade
|
Total Debt Issued | 0.02 | 0.02 | 14.43 | 420 | 306.58 | 350.52 | Upgrade
|
Long-Term Debt Repaid | - | -16.7 | -426.47 | -238.12 | -383.49 | -466.38 | Upgrade
|
Total Debt Repaid | -16.7 | -16.7 | -426.47 | -238.12 | -383.49 | -466.38 | Upgrade
|
Net Debt Issued (Repaid) | -16.68 | -16.68 | -412.04 | 181.88 | -76.91 | -115.86 | Upgrade
|
Issuance of Common Stock | - | - | - | 22.13 | 28.01 | - | Upgrade
|
Repurchase of Common Stock | - | - | - | - | - | -83.57 | Upgrade
|
Common Dividends Paid | -885.11 | -885.2 | -588.51 | -416.7 | -212.19 | -594.01 | Upgrade
|
Other Financing Activities | -41.34 | -40.63 | -38.28 | -33.87 | -48.24 | 9.84 | Upgrade
|
Financing Cash Flow | -943.13 | -942.51 | -1,039 | -246.57 | -309.33 | -783.6 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.18 | -0.3 | 0.23 | -0.02 | - | - | Upgrade
|
Net Cash Flow | -2,558 | -1,248 | -112.71 | 1,084 | -333.82 | 182.42 | Upgrade
|
Free Cash Flow | -495.96 | -400.27 | 740.52 | 1,822 | 746.92 | 957.14 | Upgrade
|
Free Cash Flow Growth | - | - | -59.37% | 144.00% | -21.96% | 57.66% | Upgrade
|
Free Cash Flow Margin | -19.66% | -11.85% | 12.99% | 35.77% | 16.74% | 27.65% | Upgrade
|
Free Cash Flow Per Share | -0.85 | -0.68 | 1.27 | 3.11 | 1.28 | 1.64 | Upgrade
|
Cash Income Tax Paid | 370.5 | 459.29 | 723.41 | 579.81 | 565.31 | 436.69 | Upgrade
|
Levered Free Cash Flow | -539.04 | -504.18 | 349.11 | 1,537 | 698.11 | 530.97 | Upgrade
|
Unlevered Free Cash Flow | -536.87 | -501.96 | 352.84 | 1,543 | 704.48 | 535.59 | Upgrade
|
Change in Net Working Capital | 759.7 | 879.72 | 420.94 | -786.7 | -170.77 | -183.82 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.